Meta facebook tracking pixel

Listen Now

Topics Covered

  • Updates on the Treatment of Metastatic Triple Negative Breast Cancer, in the Context of COVID-19
  • Novel Treatment Therapies
  • Clinical Trial Updates
  • How Research Offers Additional Treatment Options
  • Biomarkers, Diagnostic Testing & Genomics: Why They Are So Important
  • The Role of Precision Medicine in Improving Treatment Decisions
  • Sequencing of Treatments
  • Tips to Prevent & Manage Side Effects, Symptoms, Discomfort & Pain
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments to Reduce Your Exposure to COVID-19
  • Key Questions to Ask Your Health Care Team, including Lifestyle & Quality-of-Life Concerns
  • Practical Strategies to Cope with Metastatic Triple Negative Breast Cancer
  • How to Find the Financial, Emotional & Social Supports to Cope
  • Questions for Our Panel of Experts

Our Panel of Experts

Presenter

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Presenter

Filipa Lynce, MD

Breast Medical Oncologist, Dana-Farber Cancer Institute, Harvard Medical School

Presenter

Roberto A. Leon-Ferre, MD

Assistant Professor of Oncology, Consultant, Division of Medical Oncology, Mayo Clinic

Presenter

Hayley Dinerman, JD

Co-Founder and Executive Director Triple Negative Breast Cancer Foundation®

Presenter

Sam Fortune, MSW

Oncology Social Worker, CancerCare

Brochure

You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on October 06, 2021.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.